Article
02 Oct 2024
PM(NOC) Regulations: Seven-year Anniversary Of Major Amendments
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada
AUTHORS CONTENT
Article
30 Aug 2024
Manitoba Last Province To Introduce Biosimilars Initiative, While Ontario Adds Four Drugs To Its Biosimilar Policy
Article
12 Jul 2024
2024 Mid-Year Highlights In Canadian Life Sciences IP And Regulatory Law
Article
01 Apr 2024
Update On Biosimilars In Canada – March 2024
Article
26 Jan 2024
Federal Court Finds PMPRB Reasonably Concluded Galderma's Patent Claiming 0.3% Adapalene "Pertained To" 0.1% Adapalene DIFFERIN
Article
15 Jan 2024
2023 Highlights in Canadian Life Sciences IP and Regulatory Law
Article
02 Jan 2024
Government Of Canada Announces Creation Of Canadian Drug Agency
Article
20 Nov 2023
PMPRB Publishes Scoping Paper For Consultation On Guidelines And Invites Stakeholder Feedback
Article
31 Oct 2023
PMPRB News: Upcoming Roundtable As First Phase Of New Guidelines Consultation, Two New Appointments
Article
26 Sep 2023
PM(NOC) Regulations: Six-Year Anniversary Of Major Amendments
AWARDS
